BOCK

Filler

Forehead Filler Can Round a Flat Forehead. No Layer of the Forehead Is Free of Arteries.

In Greek myth, Zeus swallows his first wife, Metis, and is later seized by a splitting headache. In the version most people remember, Hephaestus takes an axe to his skull, and Athena steps out of his forehead fully grown and fully armed. The story treats the forehead as a lid: open it, and something emerges cleanly, with no harm done.

A woman in her early thirties turns her profile to the mirror and runs her palm from her brow to her hairline. Her forehead is flat and slopes slightly backwards, and she would like it rounder, without surgery. Forehead filler (an injectable gel placed over the frontal bone, also called nonsurgical forehead augmentation) is the usual answer. It can turn a flat forehead into a gentle curve, and in a randomized trial the change was still visible at six months. But the forehead is also one of the regions most often named in reports of filler-related vision loss, and its arteries are not confined to a single layer. A forehead plan should start with the arteries, not the product.


What does forehead filler actually do?

Forehead filler changes the contour of the forehead by adding volume over the frontal bone. The gel is usually placed deep, close to the bone, and spread across the central forehead so that the surface stays smooth rather than lumpy.

It does not treat the lines that appear when the eyebrows lift. Those come from the frontalis, the muscle that raises the brows, and they respond to botulinum toxin. In the trial discussed below, every patient received botulinum toxin to the frontalis 15 days before filler, and only people whose forehead irregularities had not resolved with toxin were enrolled (Scardua et al., 2024). Shape is a filler question; movement lines are a toxin question.


How well does forehead filler work in a randomized trial?

The best controlled evidence is a single randomized trial, and it compares two fillers rather than filler against no treatment. Scardua et al. (2024), in the Journal of Cosmetic Dermatology, randomized 132 adults, 66 per group, to diluted calcium hydroxylapatite (CaHA, a mineral-based filler that also stimulates collagen) or a mixture of CaHA and hyaluronic acid (HA). Patients and assessors were blinded, and all 132 completed follow-up (Scardua et al., 2024).

Treatment was a single session. The filler went into the plane just above the bone (the supraperiosteal plane) through a 21G cannula, starting 2 cm above the bony rim of the eye socket (Scardua et al., 2024).

At 30 days the groups did not differ on the Global Aesthetic Improvement Scale (p = 0.25). At 180 days the mixture scored significantly better (p < 0.01). Irregularities persisted in 11 of 66 patients given CaHA alone, against 3 of 66 given the mixture (Scardua et al., 2024).

The rest of the evidence is smaller. In a technique report in Plastic and Reconstructive Surgery Global Open, Huang and Liang (2024) treated 10 Asian women with a firm, high G-prime HA (G-prime describes how well a gel holds its shape) using a five-step method. Improvement scores were 3.0 ± 0.0 immediately after treatment, 2.5 ± 0.5 at six months and 1.8 ± 0.6 at twelve months (Huang & Liang, 2024). Ten patients without a control group cannot set expectations on their own, but the gradual drift over a year matches what is seen at other filler sites.


Why is the forehead a higher-risk site for filler?

The forehead's arteries connect with the arteries that supply the eye. If filler enters one of them and travels backwards, it can block the circulation of the retina. Blindness after filler is rare, but the forehead keeps appearing in the case literature. In a review of 48 published cases of vision loss after filler, reported between 2015 and September 2018, the forehead was involved in 18.8% of cases and the glabella (the area between the brows) in 27.1%, behind the nose at 56.3% (Beleznay et al., 2019).

HA was the filler in 81.3% of those cases. Vision recovered completely in 10 cases (20.8%) and partially in 8 (16.7%), and no treatment was consistently successful (Beleznay et al., 2019).

These percentages describe published cases, not the risk of a single injection. They cannot say how often blindness happens. They do say where it happens, and the forehead is on that list.


Where do the forehead arteries run?

Above the frontalis muscle and below it, which is why no plane is automatically safe. Cong et al. (2017), in Plastic and Reconstructive Surgery, dissected 20 half-faces from 11 cadavers and traced the supratrochlear and supraorbital arteries, the two vessels that rise from the inner and middle brow into the forehead (Cong et al., 2017).

They described two main patterns. In one, a deep branch of the supratrochlear artery ran beneath the frontalis, close to the bone. In the other, that branch was absent and a deep branch of the supraorbital artery supplied the deep layer instead. In both patterns, superficial branches supplied the layer above the muscle (Cong et al., 2017). The deep plane is not empty. It simply has different arteries.

Technique choices, such as where the entry point sits, how deep the gel goes and how slowly it is placed, are ways of working around that anatomy. They do not make it disappear.

Some will say that most forehead injections pass without incident. That is true, and the absolute risk is low. But a complication that is rare and severe is exactly the kind worth planning for, and the planning starts with knowing that every layer of the forehead carries blood.


Hyaluronic acid or calcium hydroxylapatite for the forehead?

The trials do not settle it. The randomized trial compared CaHA alone with a CaHA and HA mixture; it did not test HA alone (Scardua et al., 2024).

The practical difference is reversibility. HA can be dissolved with hyaluronidase, an enzyme, if the shape is wrong or a vascular problem is suspected. CaHA is not dissolved by this enzyme. In the trial, nodules were uncommon in both groups, 4 with CaHA alone and 1 with the mixture, a difference that was not significant (p = 0.36) (Scardua et al., 2024). In the smaller HA series, mild tenderness occurred in 10% and temporary swelling in 30%, with no vascular events (Huang & Liang, 2024).


Who does the forehead filler evidence apply to?

The randomized trial enrolled adults whose mean ages ranged from 39.6 to 47.0 years across its sex and treatment subgroups, and it compared two fillers without an untreated control (Scardua et al., 2024). The HA series included 10 Asian women with no prior filler or forehead procedures (Huang & Liang, 2024). The anatomical map comes from 11 cadavers (Cong et al., 2017).

So the evidence is encouraging but indirect for a younger patient who wants a rounder profile. The first question is still anatomical: is the forehead flat because of bone shape and volume, or are the lines she dislikes coming from muscle movement?


Conclusion

Forehead filler can round a flat forehead, and a blinded randomized trial shows the shape holding at six months, with an HA-containing mixture leaving fewer irregularities than CaHA alone. The broader evidence is small, and most of it follows patients for a year or less.

The safety picture is defined by anatomy. The forehead appears in roughly one in five published cases of filler-related vision loss, and its arteries run both above and beneath the muscle. A good consultation separates shape from movement, explains why the product chosen should ideally be reversible, and describes where the vessels lie before describing the curve.

Athena stepped out of a forehead without a scratch. Real foreheads are not lids. They are layered, supplied from above and below, and they reward the injector who knows what lies under the curve.

For clinical assessments and consultation in Seoul: itsdrbock.com

Cover image: The Birth of Athena, Attic black-figure amphora (c. 550 BC), Louvre F32. Public domain. Source: Wikimedia Commons

References

Beleznay, K., Carruthers, J. D. A., Humphrey, S., Carruthers, A., & Jones, D. (2019). Update on avoiding and treating blindness from fillers: A recent review of the world literature. Aesthetic Surgery Journal, 39(6), 662–674. https://doi.org/10.1093/asj/sjz053

Cong, L.-Y., Phothong, W., Lee, S.-H., Wanitphakdeedecha, R., Koh, I., Tansatit, T., & Kim, H.-J. (2017). Topographic analysis of the supratrochlear artery and the supraorbital artery: Implication for improving the safety of forehead augmentation. Plastic and Reconstructive Surgery, 139(3), 620e–627e. https://doi.org/10.1097/PRS.0000000000003060

Huang, Y.-L., & Liang, B. C.-P. (2024). Evolving forehead augmentation: A five-step approach with high G prime hyaluronic acid. Plastic and Reconstructive Surgery Global Open, 12(1), e5549. https://doi.org/10.1097/GOX.0000000000005549

Scardua, N., Rovaris, D. P., Moreira, K. M. S., Guimarães, A. L. S., & Scardua, M. T. (2024). Supraperiosteal technique protocol for forehead filling with a mixture of calcium hydroxyapatite and hyaluronic acid: Double-blind, randomized controlled clinical trial. Journal of Cosmetic Dermatology, 23(12), 4116–4122. https://doi.org/10.1111/jocd.16488

More From the Blog